Details

Autor(en) / Beteiligte

• Hirata, Wataru
• Itatani, Yoshiro
• Masui, Hideyuki
• Kawada, Kenji
• Mizuno, Rei
• Yamamoto, Takamasa
• Okamoto, Takuya
• Ogawa, Ryotaro
• Inamoto, Susumu
• Maekawa, Hisatsugu
• Okamura, Ryosuke
• Kiyasu, Yoshiyuki
• Hanada, Keita
• Okamoto, Michio
• Nishikawa, Yasuyo
• Sugimoto, Naoko
• Tamura, Takuya
• Hatano, Etsuro
• Sakai, Yoshiharu
• Obama, Kazutaka

Titel

Downregulation of osteoprotegerin in colorectal cancer cells promotes liver metastasis via activating tumor-associated macrophage

Ist Teil von

• Scientific reports, 2023-12, Vol.13 (1), p.22217-22217, Article 22217

Ort / Verlag

London: Nature Publishing Group UK

Erscheinungsjahr

2023

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Osteoprotegerin (OPG) is a secreted cytokine that functions as a decoy receptor for receptor activator of nuclear factor kappa-B (RANK) ligand (RANKL). Anti-RANKL treatment for bone metastasis has been widely accepted for solid tumors. However, the mechanism of OPG-RANKL-RANK signaling in systemic colorectal cancer (CRC) metastasis remains unclear. In this study, we investigated the relevance and function of OPG expression in CRC liver metastasis. First, we performed in silico analysis using The Cancer Genome Atlas public database and found that lower OPG expression in CRC was associated with poor overall survival. Immunohistochemistry analyses using resected specimen from patients with CRC in our institute confirmed the result. Patient-matched primary CRC and liver metastases showed a significant downregulation of OPG expression in metastatic lesions. In CRC cell lines, OPG expression did not suppress cell proliferation and migration. However, OPG expression inhibited macrophage migration by suppressing the RANKL-RANK pathway. Moreover, in vivo mouse liver metastasis models showed that OPG expression in CRC cells suppressed liver metastases. In addition, treatment with an anti-RANKL neutralizing antibody also suppressed liver metastases. These results showed that downregulation of OPG expression in CRC cells promotes liver metastasis by activating tumor-associated macrophage, which can become a candidate for targeted therapy with anti-RANKL neutralizing antibody for CRC liver metastasis.